Current Trends in Biosimilars

Journal Title: Journal of Pharmaceutical and Biomedical Sciences - Year 2016, Vol 6, Issue 5

Abstract

Recombinant technology has brought a wide availability of the treatment options for many life-threatening diseases. Consistent with the great inventions in the area of biotechnology, biopharmaceuticals have become the fastest growing area of the pharmaceutical industry. The recent expiration of many innovator biopharmaceutical products has triggered the development of alternate versions of originators biologic drugs. Unlike generic drugs, these new biological products are not the identical copies of innovator products. Thus, these alternate versions are referred to as ‘follow-on biologics’ or ‘biosimilar drugs’. Slight changes in starting materials or modification in the manufacturing processes have significant impact on the final structure of the biologic molecule. Thus, the exact structure of the originator’s biologic molecule cannot be duplicated. This makes these biosimilars very unique molecules necessitating the need for elaborate characterisation and consistent pharmacovigilance.

Authors and Affiliations

Bhagyashri Surendra Parab, Supriya S. Shidhaye, Ruchi Singh

Keywords

Related Articles

Transdermal Pharmacotherapy: Traditions and Innovations

The review is focused on the development questions and transdermal medicines usage. The advantages and limitations for transdermal drug administration are presented. The analysis of 70 scientific sources is performed. Th...

Arteriovenous Malformation of the Oral Cavity: A Case Report and Review of Literature

Arteriovenous malformations (AVMs) are developmental vascular anomalies that occur when the embryonic vascular network fails to differentiate. It is composed of abnormal communications between arteries and veins without...

Reason Analysis for Suspension/Early Termination of Drug Clinical Trial

Object To collect a scientific basis for improving the quality and success rate of drug clinical trials by analyzing the reasons for the suspension or termination of clinical trials in China and abroad. Method Drug Clini...

Metastatic Cervical Lymphadenopathy – Diagnosis by FNAC, A Tertiary Hospital-based Study

Objectives Cervical lymphadenopathy is one of the commonest presentations in metastatic tumours. Fine needle aspiration cytology (FNAC) is a simple, cost effective, and rapid method for the diagnosis of metastatic cervic...

Symptoms and Management of Glue Ear in School Going Children: A Prospective Study

Aims To document clinical profile (presenting manifestation, hearing assessment) of persistent otitis media with effusion (OME) with hearing impairment in children. To compare the improvement in hearing after non-surgica...

Download PDF file
  • EP ID EP183674
  • DOI -
  • Views 100
  • Downloads 0

How To Cite

Bhagyashri Surendra Parab, Supriya S. Shidhaye, Ruchi Singh (2016). Current Trends in Biosimilars. Journal of Pharmaceutical and Biomedical Sciences, 6(5), 286-292. https://europub.co.uk/articles/-A-183674